These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30563522)

  • 1. Predictors of clinical response to extrafine and non-extrafine particle inhaled corticosteroids in smokers and ex-smokers with asthma.
    Gafar F; Boudewijn IM; Cox CA; Vonk JM; Schokker S; Lexmond AJ; Frijlink HW; Hagedoorn P; Postma DS; van den Berge M
    Respir Res; 2018 Dec; 19(1):256. PubMed ID: 30563522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extrafine compared to non-extrafine particle inhaled corticosteroids in smokers and ex-smokers with asthma.
    Cox CA; Boudewijn IM; Vroegop SJ; Schokker S; Lexmond AJ; Frijlink HW; Hagedoorn P; Vonk JM; Farenhorst MP; Ten Hacken NHT; Kerstjens HAM; Postma DS; van den Berge M
    Respir Med; 2017 Sep; 130():35-42. PubMed ID: 29206631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of initiating extrafine-particle versus fine-particle inhaled corticosteroids as asthma therapy in the Netherlands.
    van der Molen T; Postma DS; Martin RJ; Herings RM; Overbeek JA; Thomas V; Miglio C; Dekhuijzen R; Roche N; Guilbert T; Israel E; van Aalderen W; Hillyer EV; van Rysewyk S; Price DB
    BMC Pulm Med; 2016 May; 16(1):80. PubMed ID: 27184175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-Life Outcomes for Patients with Asthma Prescribed Spacers for Use with Either Extrafine- or Fine-Particle Inhaled Corticosteroids.
    Guilbert TW; Colice G; Grigg J; van Aalderen W; Martin RJ; Israel E; Postma DS; Roche N; Phipatanakul W; Hillyer EV; Evans JM; Dolovich MB; Price DB;
    J Allergy Clin Immunol Pract; 2017; 5(4):1040-1049.e4. PubMed ID: 28110057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-life comparison of beclometasone dipropionate as an extrafine- or larger-particle formulation for asthma.
    Price D; Thomas M; Haughney J; Lewis RA; Burden A; von Ziegenweidt J; Chisholm A; Hillyer EV; Corrigan CJ
    Respir Med; 2013 Jul; 107(7):987-1000. PubMed ID: 23643486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD.
    Postma DS; Roche N; Colice G; Israel E; Martin RJ; van Aalderen WM; Grigg J; Burden A; Hillyer EV; von Ziegenweidt J; Gopalan G; Price D
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1163-86. PubMed ID: 25378918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extrafine Versus Fine Inhaled Corticosteroids in Relation to Asthma Control: A Systematic Review and Meta-Analysis of Observational Real-Life Studies.
    Sonnappa S; McQueen B; Postma DS; Martin RJ; Roche N; Grigg J; Guilbert T; Gouder C; Pizzichini E; Niimi A; Phipatanakul W; Chisholm A; Dandurand RJ; Kaplan A; Israel E; Papi A; van Aalderen WMC; Usmani OS; Price DB
    J Allergy Clin Immunol Pract; 2018; 6(3):907-915.e7. PubMed ID: 28941668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized trial of allergen-induced asthmatic response in smokers and non-smokers: effects of inhaled corticosteroids.
    Cahn A; Boyce M; Mistry S; Musani N; Rambaran C; Storey J; Ventresca P; Michel O
    Clin Exp Allergy; 2015 Oct; 45(10):1531-41. PubMed ID: 26251958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of initiating extrafine- or standard size-particle inhaled corticosteroid for asthma in two health-care systems: a retrospective matched cohort study.
    Martin RJ; Price D; Roche N; Israel E; van Aalderen WM; Grigg J; Postma DS; Guilbert TW; Hillyer EV; Burden A; von Ziegenweidt J; Colice G
    NPJ Prim Care Respir Med; 2014 Oct; 24():14081. PubMed ID: 25297072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased periostin associates with greater airflow limitation in patients receiving inhaled corticosteroids.
    Kanemitsu Y; Matsumoto H; Izuhara K; Tohda Y; Kita H; Horiguchi T; Kuwabara K; Tomii K; Otsuka K; Fujimura M; Ohkura N; Tomita K; Yokoyama A; Ohnishi H; Nakano Y; Oguma T; Hozawa S; Nagasaki T; Ito I; Oguma T; Inoue H; Tajiri T; Iwata T; Izuhara Y; Ono J; Ohta S; Tamari M; Hirota T; Yokoyama T; Niimi A; Mishima M
    J Allergy Clin Immunol; 2013 Aug; 132(2):305-12.e3. PubMed ID: 23791506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Step-down of inhaled corticosteroids in non-eosinophilic asthma: A prospective trial in real life.
    Demarche S; Schleich F; Henket M; Paulus V; Louis R; Van Hees T
    Clin Exp Allergy; 2018 May; 48(5):525-535. PubMed ID: 29383782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High strength extrafine pMDI beclometasone/formoterol (200/6 μg) is effective in asthma patients not adequately controlled on medium-high dose of inhaled corticosteroids.
    Paggiaro P; Corradi M; Latorre M; Raptis H; Muraro A; Gessner C; Siergiejko Z; Scuri M; Petruzzelli S
    BMC Pulm Med; 2016 Dec; 16(1):180. PubMed ID: 27938358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of frequent exacerbations in (ex)smoking and never smoking adults with severe asthma.
    Westerhof GA; de Groot JC; Amelink M; de Nijs SB; Ten Brinke A; Weersink EJ; Bel EH
    Respir Med; 2016 Sep; 118():122-127. PubMed ID: 27578481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-life effectiveness of extrafine beclometasone dipropionate/formoterol in adults with persistent asthma according to smoking status.
    Brusselle G; Peché R; Van den Brande P; Verhulst A; Hollanders W; Bruhwyler J
    Respir Med; 2012 Jun; 106(6):811-9. PubMed ID: 22357130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Particle size of inhaled corticosteroids: does it matter?
    Leach C; Colice GL; Luskin A
    J Allergy Clin Immunol; 2009 Dec; 124(6 Suppl):S88-93. PubMed ID: 19962042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of asthma control indicators in measuring inhaled corticosteroid effectiveness in asthmatic smokers: a systematic review.
    Hayes CE; Nuss HJ; Tseng TS; Moody-Thomas S
    J Asthma; 2015; 52(10):996-1005. PubMed ID: 26418843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do asthmatic smokers benefit as much as non-smokers on budesonide/formoterol maintenance and reliever therapy? Results of an open label study.
    van Schayck OC; Haughney J; Aubier M; Selroos O; Ekström T; Ostinelli J; Buhl R
    Respir Med; 2012 Feb; 106(2):189-96. PubMed ID: 22119455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind comparison of beclomethasone dipropionate extrafine aerosol and fluticasone propionate.
    Fairfax A; Hall I; Spelman R
    Ann Allergy Asthma Immunol; 2001 May; 86(5):575-82. PubMed ID: 11379810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled corticosteroid dose response in asthma: Should we measure inflammation?
    Anderson WJ; Short PM; Jabbal S; Lipworth BJ
    Ann Allergy Asthma Immunol; 2017 Feb; 118(2):179-185. PubMed ID: 28065396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of inhaled corticosteroid particle size on asthma efficacy and safety outcomes: a systematic literature review and meta-analysis.
    El Baou C; Di Santostefano RL; Alfonso-Cristancho R; Suarez EA; Stempel D; Everard ML; Barnes N
    BMC Pulm Med; 2017 Feb; 17(1):31. PubMed ID: 28173781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.